Cristiana Lo Nigro

ORCID: 0000-0002-3615-2431
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Hypoxia, and Metabolism
  • Epigenetics and DNA Methylation
  • Cancer Research and Treatments
  • Cancer Immunotherapy and Biomarkers
  • Cancer-related gene regulation
  • Head and Neck Cancer Studies
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Treatments and Mutations
  • Amino Acid Enzymes and Metabolism
  • RNA modifications and cancer
  • Cancer Genomics and Diagnostics
  • Cancer-related Molecular Pathways
  • Cancer Treatment and Pharmacology
  • Cancer-related molecular mechanisms research
  • Genetics and Neurodevelopmental Disorders
  • CAR-T cell therapy research
  • HER2/EGFR in Cancer Research
  • Cancer Cells and Metastasis
  • Angiogenesis and VEGF in Cancer
  • Monoclonal and Polyclonal Antibodies Research
  • Immune Cell Function and Interaction
  • Prostate Cancer Treatment and Research
  • Circular RNAs in diseases
  • PI3K/AKT/mTOR signaling in cancer
  • Receptor Mechanisms and Signaling

Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo
2013-2022

Ente Ospedaliero Ospedali Galliera
1996-2022

Creative Research Enterprises (United States)
2016

Cancer Genetics (United States)
2012-2016

Centre Antoine Lacassagne
2007-2016

University of Genoa
2015

AGH University of Krakow
2013

Southern Taiwan University of Science and Technology
2013

Wellcome Trust
2013

Medical Research Council
2013

Classical lissencephaly (smooth brain) or generalized agyriapachygyria is a severe brain malformation which results from an arrest of neuronal migration at 9–13 weeks gestation. It has been observed in several syndromes including Miller-Dieker syndrome (MDS) and isolated sequence (ILS). A gene containing β-transducin like repeats, now known as LIS1, was previously mapped to the ILS/MDS chromosome region on 17p13.3. We recently localized classical critical LIS1 locus by molecular analysis key...

10.1093/hmg/6.2.157 article EN Human Molecular Genetics 1997-02-01

Arginine deprivation, either by nutritional starvation or exposure to ADI-PEG20, induces adaptive transcriptional upregulation of ASS1 and ASL in glioblastoma multiforme ex vivo cultures cell lines. This is blocked neoplasia-specific CpG island methylation gene, causing arginine auxotrophy death. In cells with methylated islands, ADI-PEG20 initially a protective autophagic response, but abrogation this chloroquine accelerates potentiates cytotoxicity. Concomitant the islands both ASL,...

10.1038/cddis.2012.197 article EN cc-by Cell Death and Disease 2013-01-17

Targeted therapies have yet to significant impact on the survival of patients with bladder cancer. In this study, we focused urea cycle enzyme argininosuccinate synthetase 1 (ASS1) as a therapeutic target in cancer, based our discovery prognostic and functional import ASS1 setting. expression status tumors from 183 Caucasian 295 Asian was analyzed, along its hypothesized association clinicopathologic features, including tumor size invasion. Furthermore, genetics, biology, implications loss...

10.1158/0008-5472.can-13-1702 article EN Cancer Research 2013-11-28

The cytokine TGF-β acts as a tumor suppressor in normal epithelial cells and during the early stages of tumorigenesis. During malignant progression, cancer can switch their response to use this potent oncogenic factor; however, mechanistic basis for is poorly understood. Here we demonstrate that downregulation disabled homolog 2 (DAB2) gene expression via promoter methylation frequently occurs human squamous cell carcinomas (SCCs) an independent predictor metastasis poor prognosis....

10.1172/jci36125 article EN Journal of Clinical Investigation 2010-06-30

Novel prognostic biomarkers and therapeutic strategies are urgently required for malignant melanoma. Ecto-5-prime-nucleotidase (NT5E; CD73) overexpression has been reported in several human cancers. The mechanism(s) underlying deregulated expression the clinical consequences of changes not known. We used RT–PCR, qPCR, methylation-specific PCR pyrosequencing to analyse regulation NT5E melanoma cell lines primary metastatic melanomas. is subject epigenetic mRNA downregulated by...

10.1038/bjc.2012.95 article EN cc-by-nc-sa British Journal of Cancer 2012-03-27

Positive Platelia Aspergillus test results were observed in consecutive serum samples from an immunocompromised host during amoxicillin-clavulanic acid treatment, and a correlation between plasmatic amoxicillin concentration galactomannan optical density index was observed. Amoxicillin-clavulanic vials tested positive for but negative DNA.

10.1128/jcm.42.11.5362-5363.2004 article EN Journal of Clinical Microbiology 2004-11-01

Argininosuccinate synthase 1 (ASS1) is the rate-limiting enzyme for arginine biosynthesis. ASS1 expression lost in a range of tumor types, including 50% malignant pleural mesotheliomas. Starving ASS1-deficient cells with blockers such as ADI-PEG20 can induce selective lethality and has shown great promise clinical setting. We have generated model resistance mesothelioma cells. This mediated through re-expression via demethylation promoter. Through coordinated transcriptomic metabolomic...

10.1016/j.celrep.2016.06.097 article EN cc-by-nc-nd Cell Reports 2016-07-21
Vera Hirsh Sandro Pignata Melissa Bersanelli Letizia Gnetti Cinzia Azzoni and 95 more Lorena Bottarelli Donatello Gasparro Francesco Toni Enrico Maria Silini Sebastiano Buti Erik Wennerberg Aranzazu Mediero Bruce N. Cronstein Silvia C. Formenti Sandra Demaria Claire Vanpouille‐Box Karsten A. Pilones Nils-Petter Rudqvist J.R. Diamond Silvia C. Formenti Sandra Demaria Zachary S. Morris Emily I. Guy David M. Francis Monica M. Gressett Eric A. Armstrong Shyhmin Huang Stephen D. Gilles Alan J. Korman Jacquelyn A. Hank Anna Hoefges Alexander L. Rakhmilevich Paul M. Harari Paul M. Sondel Yared Hailemichael Willem W. Overwijk Per thor Straten Alessandro Lugli Heather Dawson Annika Blank Inti Zlobec Luigi Fattore Susan Costantini Mario Acunzo Giulia Romano Giovanni Nigita Antonio Simone Laganà Debora Malpicci Ciro Francesco Ruggiero Maria Elena Pisanu Alessia Noto Claudia De Vitis Carlo M. Croce Paolo A. Ascierto Rita Mancini Gennaro Ciliberto Michael A. Postow Jason J. Luke David F. Stroncek Luciano Castiello Wenjing Chen Ping Jin Jiaqiang Ren Marianna Sabatino Soldano Ferrone Connie P.M. Duong Marie Vétizou Laurence Zitvogel Maria Elena Pisanu Alessia Noto Luigi Fattore Debora Malpicci Gennaro Ciliberto Rita Mancini Marcella Occelli Carolina Cauchi Grazia Sciancalepore Cristiana Lo Nigro Michela Rovera Chiara Varamo Daniela Vivenza Zelda Seia S. Palazzini Fabiana Errico Davide Basso Laura Quaranta Giuseppe Forte Fulvio Lavagna Silvia Violante Paolo Bosio Laura Lattanzio Marco Merlano Duane Moogk Zhong Shi Zhiya Yu Ivan Liadi William Rittase Victoria Fang Janna Dougherty Arianne Pérez-García

Background: NSCLC remains a challenging disease to treat, especially because the majority of patients present with advanced [1].For many these standard first-line therapy is platinumbased chemotherapy, which can prolong survival by 8-12 months in some and also improve disease-related symptoms [2].The chemotherapy treatments are frequently poorly tolerated.Treatment choices following limited, approved options include docetaxel, pemetrexed erlotinib.Recent developments immunotherapies approval...

10.1186/s12967-016-1095-2 article EN cc-by Journal of Translational Medicine 2017-01-01
Coming Soon ...